| ²é¿´: 332 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
cainiaoduiгæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖú·Òë
|
||
| As a result, vessel structure and function become more normal: vessels are more mature with enhanced PVC coverage, blood flow is more homogeneous, vessel permeability and hypoxia are reduced, and importantly the delivery of systemically administered anticancer therapies into tumors is more uniform. This concept explains why antiangiogenic therapy¡¯s benefit has often been observed when it is given with chemotherapy |
» ²ÂÄãϲ»¶
322Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
295·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
294Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
±¾ÈËÅ®º¢
ÒѾÓÐ10È˻ظ´
¶þ±½¼×ͪËáÀàÑÜÉúÎï
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸Öпƴó²ÄÁÏÓ뻯¹¤£¬353·Ö»¹Óе÷¼ÁѧУÂð
ÒѾÓÐ11È˻ظ´
335Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
279Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ39È˻ظ´
reko34
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 132
- Ó¦Öú: 117 (¸ßÖÐÉú)
- ½ð±Ò: 4794.2
- É¢½ð: 22
- ºì»¨: 12
- Ìû×Ó: 780
- ÔÚÏß: 417.4Сʱ
- ³æºÅ: 3055206
- ×¢²á: 2014-03-15
- ÐÔ±ð: GG
- רҵ: »úе²âÊÔÀíÂÛÓë¼¼Êõ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
RXMCDM: ½ð±Ò+1 2014-05-07 12:29:37
cainiaodui: ½ð±Ò+5, ·ÒëEPI+1 2014-05-07 13:32:37
RXMCDM: ½ð±Ò+1 2014-05-07 12:29:37
cainiaodui: ½ð±Ò+5, ·ÒëEPI+1 2014-05-07 13:32:37
| µÃµ½µÄÒ»¸ö½á¹ûÊÇ£¬Ñª¹Ü½á¹¹ºÍ¹¦ÄܱäµÃ¸ü¼ÓÕý³££ºÔöÇ¿µÄPVC¸²¸ÇʹѪ¹Ü¸ü³ÉÊ죬ѪÁ÷¸ü¾ùÔÈ£¬Ñª¹ÜÉøÍ¸ÐÔºÍȱÑõ¼õÉÙ£¬ÖØÒªµÄÊÇÈ«ÉíÐÔÊ©ÓõĿ¹°©ÁÆ·¨¸ü¾ùÔȵؽøÈëÖ×Áö¡£ÕâÖÖ¹Ûµã½âÊÍÁËΪʲô»¯ÁÆÖо³£¹Û²ìµ½¿¹°©ÁÆ·¨µÄÒæ´¦¡£ |
2Â¥2014-05-07 11:39:29













»Ø¸´´ËÂ¥